AACR Virtual Patient Advocate Forum
revolution in cancer clinical trials
Tuesday, November 29, 2022
Clinical trials in oncology are increasing in complexity due to enrollment challenges, protocol deviations, and a staggering amount of data that are increasing costs and adding months to their timelines. Innovative trial designs may help address some of these challenges. This Forum will review the standard features of the traditional or gold-standard randomized clinical trials and discuss innovative trial designs that are changing the way new treatments are developed for patients with cancer.
Anna D. Barker, PhD, FAACR, Ellison Institute for Transformative Medicine
Margaret Foti, PhD, MD (hc), American Association for Cancer Research
Jane Perlmutter, PhD, MBA, Gemini Group
Douglas Yee, MD, University of Minnesota School of Medicine
Roy S. Herbst, MD, PhD, Yale School of Medicine
Louis M. Weiner, MD, Georgetown Lombardi Comprehensive Cancer CenterProgram Agenda Speaker Bios
AACR Patient Advocate Forums
The AACR is committed to providing educational programming to patients with cancer and patient advocacy communities to support their collective mission to find cures for all cancers. AACR Patient Advocate Forums invite leaders from patient advocacy, academia, industry, and healthcare communities to discuss pressing topics and the latest discoveries in cancer research. These virtual forums are provided quarterly at no cost to attendees and open to the public.